General Introduction to QSAR

[1]  E. C. Herrmann,et al.  Computer Aided Drug Design in Industrial Research , 1995, Ernst Schering Research Foundation Workshop.

[2]  Han van de Waterbeemd,et al.  Chemometric Methods in Molecular Design: van de Waterbeemd/Chemometric , 1995 .

[3]  Michael Wiese,et al.  Drug-membrane interactions : analysis, drug distribution, modeling , 2002 .

[4]  G. Cruciani,et al.  Generating Optimal Linear PLS Estimations (GOLPE): An Advanced Chemometric Tool for Handling 3D‐QSAR Problems , 1993 .

[5]  C. Hansch,et al.  p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure , 1964 .

[6]  I V Tetko,et al.  Volume learning algorithm artificial neural networks for 3D QSAR studies. , 2001, Journal of medicinal chemistry.

[7]  H. Kubinyi QSAR: Hansch Analysis and Related Approaches: Kubinyi/QSAR , 1993 .

[8]  H. Kubinyi,et al.  3D QSAR in drug design. , 2002 .

[9]  S. Free,et al.  A MATHEMATICAL CONTRIBUTION TO STRUCTURE-ACTIVITY STUDIES. , 1964, Journal of medicinal chemistry.

[10]  Gabriele Cruciani,et al.  GOLPE-Guided Region Selection , 1998 .

[11]  J. Topliss,et al.  Chance factors in studies of quantitative structure-activity relationships. , 1979, Journal of medicinal chemistry.

[12]  James W. McFarland,et al.  On Identifying Likely Determinants of Biological Activity in High Dimensional QSAR Problems , 1994 .

[13]  A. Leo CALCULATING LOG POCT FROM STRUCTURES , 1993 .

[14]  Anton J. Hopfinger,et al.  Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships , 1994, J. Chem. Inf. Comput. Sci..

[15]  P. N. Craig,et al.  Quantitative structure-activity relationships in 1-aryl-2-(alkylamino)ethanol antimalarials. , 1979, Journal of medicinal chemistry.

[16]  H. Kubinyi,et al.  A scoring scheme for discriminating between drugs and nondrugs. , 1998, Journal of medicinal chemistry.

[17]  Gabriele Cruciani,et al.  A New Set of Principal Properties for Heteroaromatics Obtained by GRID , 1996 .

[18]  Daniel E. Platt,et al.  Comparative molecular moment analysis (CoMMA) , 1998 .

[19]  David E. Leahy,et al.  Model solvent systems for QSAR. Part 3. An LSER analysis of the ‘critical quartet.’ New light on hydrogen bond strength and directionality , 1992 .

[20]  Ulf Norinder,et al.  Prediction of Polar Surface Area and Drug Transport Processes Using Simple Parameters and PLS Statistics , 2000, J. Chem. Inf. Comput. Sci..

[21]  G. Klopman Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules , 1985 .

[22]  Han van de Waterbeemd,et al.  Computer-Assisted Lead Finding and Optimization , 1997 .

[23]  Corwin Hansch,et al.  Comparative QSAR: Toward a Deeper Understanding of Chemicobiological Interactions. , 1996, Chemical reviews.

[24]  E. Möller Chemische Struktur und biologische Aktivität von Wirkstoffen. Methoden der Quantitativen Struktur‐Wirkung‐Analyse. Von J. K. Seydel und K.‐J. Schaper. Verlag Chemie, Weinheim 1979. XI, 359 S., geb. DM 118.00 , 1980 .

[25]  Ulf Norinder,et al.  Recent Progress in CoMFA Methodology and Related Techniques , 1998 .

[26]  H. Kubinyi QSAR : Hansch analysis and related approaches , 1993 .

[27]  Toshio Fujita,et al.  Classical and Three-Dimensional QSAR in Agrochemistry , 1995 .

[28]  Robert Bywater,et al.  Improving the Odds in Discriminating "Drug-like" from "Non Drug-like" Compounds , 2000, J. Chem. Inf. Comput. Sci..

[29]  M. Feher,et al.  A simple model for the prediction of blood-brain partitioning. , 2000, International journal of pharmaceutics.

[30]  Rainer Franke,et al.  Topological Pharmacophores New Methods and Their Application to a Set of Antimalarials Part 1: The Methods LOGANA and LOCON , 1985 .

[31]  S. Wold,et al.  PLS: Partial Least Squares Projections to Latent Structures , 1993 .

[32]  Variable selection in PLS analysis , 1993 .

[33]  A. Leo,et al.  Chem-bioinformatics: comparative QSAR at the interface between chemistry and biology. , 2002, Chemical reviews.

[34]  Svante Wold,et al.  D-Optimal Designs in QSAR , 1993 .

[35]  Corwin Hansch,et al.  A survey of Hammett substituent constants and resonance and field parameters , 1991 .

[36]  A. Hopfinger A QSAR investigation of dihydrofolate reductase inhibition by Baker triazines based upon molecular shape analysis , 1980 .

[37]  Y. Martin,et al.  Quantitative structure--activity relationships in leucomycin and lincomycin antibiotics. , 1971, Journal of medicinal chemistry.

[38]  R. Franke,et al.  EVAL — A New Tool to Evaluate Topological Pharmacophores , 1991 .

[39]  H S Rosenkranz,et al.  Toxicity estimation by chemical substructure analysis: the TOX II program. , 1995, Toxicology letters.

[40]  Gerd Folkers,et al.  Pharmacokinetic optimization in drug research , 2001 .

[41]  Vladimir Poroikov,et al.  Robustness of Biological Activity Spectra Predicting by Computer Program PASS for Noncongeneric Sets of Chemical Compounds , 2000, J. Chem. Inf. Comput. Sci..

[42]  Gerhard Klebe,et al.  Comparative Molecular Similarity Indices Analysis: CoMSIA , 1998 .

[43]  V. Kulkarni,et al.  Multiple Regression and Principal Component Analysis of Antibacterial Activities of Sulfones and Sulfonamides in Whole Cell and Cell-Free Systems of Various DDS Sensitive and Resistant Bacterial Strains , 1985 .

[44]  Vladimir Poroikov,et al.  Chemical Similarity Assessment through Multilevel Neighborhoods of Atoms: Definition and Comparison with the Other Descriptors , 1999, J. Chem. Inf. Comput. Sci..

[45]  Nenad Trinajstic,et al.  Nonlinear Multivariate Regression Outperforms Several Concisely Designed Neural Networks on Three QSPR Data Sets , 2000, J. Chem. Inf. Comput. Sci..

[46]  Gabriele Cruciani,et al.  Principal Properties for Aromatic Substituents. A Multivariate Approach for Design in QSAR , 1989 .

[47]  C. Hansch,et al.  Chem-bioinformatics and QSAR: a review of QSAR lacking positive hydrophobic terms. , 2001, Chemical reviews.

[48]  Nenad Trinajstic,et al.  Multivariate Regression Outperforms Several Robust Architectures of Neural Networks in QSAR Modeling , 1999, J. Chem. Inf. Comput. Sci..

[49]  Yvonne C. Martin,et al.  3D QSAR: current state, scope, and limitations , 1998 .

[50]  Hxugo Kubiny Variable Selection in QSAR Studies. I. An Evolutionary Algorithm , 1994 .

[51]  Han van de Waterbeemd,et al.  Lipophilicity in Drug Action and Toxicology: Pliška/Lipophilicity , 1996 .

[52]  Jens Sadowski,et al.  The Use of Self-organizing Neural Networks in Drug Design , 2002 .

[53]  Corwin Hansch,et al.  Role of hydrophobic effects in mechanistic QSAR , 1999 .